BioCentury | Sep 6, 2004
Strategy

Back to School 2004: Asset accumulation

...company’s partnerships have generated $10 million to date. Two small deals in 2002 - with Cerylid Biosciences Ltd....
BioCentury | Nov 4, 2002
Company News

Cerylid, Peter MacCallum Cancer Institute deal

...prior deal, the institute is running preclinical studies on the company’s CBL 316 cancer compound. Cerylid Biosciences Ltd....
BioCentury | Aug 26, 2002
Company News

Cerylid scientific advisory board update

Cerylid Biosciences Ltd. , Victoria, Australia Business: Genomics, High throughput screening Appointed: J.J. Kim Wright, VP of medicinal chemistry and preclinical development at ChemoCentryx Inc. WIR Staff...
BioCentury | Jun 10, 2002
Company News

Anadys, Cerylid deal

...companies partnered to discover anti-infective compounds. The partnership will use Anadys's uHTS-ATLAS technology to screen Cerylid's...
...of natural compounds for hits against Anadys targets. Anadys Pharmaceuticals Inc. , San Diego, Calif. Cerylid Biosciences Ltd....
BioCentury | Jun 6, 2002
Company News

Anadys, Cerylid anti-infective deal

...Anadys (San Diego, Calif.) and Cerylid (Melbourne, Australia) partnered to discover anti-infective compounds. The partnership will...
...Australia) partnered to discover anti-infective compounds. The partnership will use Anadys's uHTS-ATLAS technology to screen Cerylid's...
BioCentury | Apr 8, 2002
Company News

Cerylid board of directors update

Cerylid Biosciences Ltd., Victoria, Australia Business: Genomics, High throughput screening Appointed: Tim Harris, president and CEO of Structural GenomiX Inc. WIR Staff...
BioCentury | Apr 8, 2002
Company News

Cerylid scientific advisory board update

Cerylid Biosciences Ltd., Victoria, Australia Business: Genomics, High throughput screening Appointed: Tim Harris, president and CEO of Structural GenomiX Inc. ; George Morstyn, SVP of development and CMO at Amgen Inc. ; and Paul Tolstoshev,...
BioCentury | Oct 29, 2001
Emerging Company Profile

Corporate Profile

Cerylid Biosciences Ltd. Victoria, Australia Technology: High throughput screening of natural products Disease focus: Cancer, autoimmune/inflammation Clinical status: Preclinical Founded: 2000 Corporate partners: Aventis S.A. , Amrad Corp., Chugai Pharmaceutical Co. Ltd. , and Oxagen Ltd. University...
BioCentury | Oct 29, 2001
Emerging Company Profile

Cerylid: Purifying nature's stew

...unwilling to build in-house, because of the complex chemical makeup of the extracts, according to Cerylid Biosciences Ltd....
...against their targets. Spun out of Amrad Corp. Ltd. (ASX:AML, Melbourne, Australia) early last year, Cerylid...
...the right of first refusal to license genes of therapeutic interest discovered by the CRC. Cerylid...
BioCentury | Sep 4, 2001
Company News

Oxagen, Cerylid deal

...which at least two sisters are affected by the condition. Oxagen Ltd. , Abingdon, U.K. Cerylid Biosciences Ltd....
Items per page:
1 - 10 of 11
BioCentury | Sep 6, 2004
Strategy

Back to School 2004: Asset accumulation

...company’s partnerships have generated $10 million to date. Two small deals in 2002 - with Cerylid Biosciences Ltd....
BioCentury | Nov 4, 2002
Company News

Cerylid, Peter MacCallum Cancer Institute deal

...prior deal, the institute is running preclinical studies on the company’s CBL 316 cancer compound. Cerylid Biosciences Ltd....
BioCentury | Aug 26, 2002
Company News

Cerylid scientific advisory board update

Cerylid Biosciences Ltd. , Victoria, Australia Business: Genomics, High throughput screening Appointed: J.J. Kim Wright, VP of medicinal chemistry and preclinical development at ChemoCentryx Inc. WIR Staff...
BioCentury | Jun 10, 2002
Company News

Anadys, Cerylid deal

...companies partnered to discover anti-infective compounds. The partnership will use Anadys's uHTS-ATLAS technology to screen Cerylid's...
...of natural compounds for hits against Anadys targets. Anadys Pharmaceuticals Inc. , San Diego, Calif. Cerylid Biosciences Ltd....
BioCentury | Jun 6, 2002
Company News

Anadys, Cerylid anti-infective deal

...Anadys (San Diego, Calif.) and Cerylid (Melbourne, Australia) partnered to discover anti-infective compounds. The partnership will...
...Australia) partnered to discover anti-infective compounds. The partnership will use Anadys's uHTS-ATLAS technology to screen Cerylid's...
BioCentury | Apr 8, 2002
Company News

Cerylid board of directors update

Cerylid Biosciences Ltd., Victoria, Australia Business: Genomics, High throughput screening Appointed: Tim Harris, president and CEO of Structural GenomiX Inc. WIR Staff...
BioCentury | Apr 8, 2002
Company News

Cerylid scientific advisory board update

Cerylid Biosciences Ltd., Victoria, Australia Business: Genomics, High throughput screening Appointed: Tim Harris, president and CEO of Structural GenomiX Inc. ; George Morstyn, SVP of development and CMO at Amgen Inc. ; and Paul Tolstoshev,...
BioCentury | Oct 29, 2001
Emerging Company Profile

Corporate Profile

Cerylid Biosciences Ltd. Victoria, Australia Technology: High throughput screening of natural products Disease focus: Cancer, autoimmune/inflammation Clinical status: Preclinical Founded: 2000 Corporate partners: Aventis S.A. , Amrad Corp., Chugai Pharmaceutical Co. Ltd. , and Oxagen Ltd. University...
BioCentury | Oct 29, 2001
Emerging Company Profile

Cerylid: Purifying nature's stew

...unwilling to build in-house, because of the complex chemical makeup of the extracts, according to Cerylid Biosciences Ltd....
...against their targets. Spun out of Amrad Corp. Ltd. (ASX:AML, Melbourne, Australia) early last year, Cerylid...
...the right of first refusal to license genes of therapeutic interest discovered by the CRC. Cerylid...
BioCentury | Sep 4, 2001
Company News

Oxagen, Cerylid deal

...which at least two sisters are affected by the condition. Oxagen Ltd. , Abingdon, U.K. Cerylid Biosciences Ltd....
Items per page:
1 - 10 of 11